Benoit J Arsenault

32PUBLICATIONS
68CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Epigenetics (incl. genome methylation and epigenomics)Cardiology (incl. cardiovascular diseases)Molecular targetsCardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Feb 04, 2026
Integrative genetic and liver transcriptomic analyses identify TRIB1AL as a target for steatotic liver disease.

Émilie Gobeil, Jérôme Bourgault, Eloi Gagnon

|Jan 29, 2026
Genetically Predicted Levels of Lipoprotein(a) and Risk of Cerebrovascular Disease.

Iyas Daghlas, Marios K Georgakis, Benoit J Arsenault

|Jul 01, 2025
Appraisal of multiple polygenic risk scores to estimate the risk of myocardial infarction and coronary artery lesions.

Hasanga D Manikpurage, Jérôme Bourgault, Ursula Houessou

|May 10, 2025
RNA interference versus antibody-based PCSK9 inhibition for the prevention of cardiovascular disease: a drug-target Mendelian randomization study.

Eloi Gagnon, Dipender Gill, Jérôme Bourgault

|Mar 31, 2025
Remnant cholesterol concentrations best explain the cardiovascular benefit of APOC3 genetic inhibition: a drug target Mendelian randomization study.

Eloi Gagnon, Dipender Gill, Stephen Burgess

|Mar 13, 2025
Impact of Lipoprotein(a) on Valvular and Cardiovascular Outcomes in Patients With Calcific Aortic Valve Stenosis.

Arnaud S Girard, Audrey Paulin, Hasanga D Manikpurage

Pageof 6

Frequent Collaborators

14 joint publications

Sébastien Thériault

11 joint publications

Hasanga D Manikpurage

10 joint publications

Patrick Mathieu

9 joint publications

Eloi Gagnon